Indevus Adds Senior VP-Clinical Development From Praecis
This article was originally published in The Pink Sheet Daily
Executive Summary
James Shipley, MD, will support medical affairs and post-marketing safety surveillance for the overactive bladder agent Sanctura. He will also evaluate development strategies for pipeline products.